Product development
Product structures are developed around controlled manual needle retraction and single-use disablement.
À propos de Xingxu Kangda
Shaanxi Xingxukangda Medical Technology développe et fabrique des seringues de sécurité rétractables stériles et des solutions automatisées associées.

Profil de l'entreprise
Xingxu Medical Devices (Suzhou) a été créée en 2016. Une unité de production a été implantée à Lintong, Shaanxi en 2023 pour le développement et la fabrication de seringues de sécurité.
L'activité intègre R&D, moules de précision, assemblage automatisé, conception de procédés propres et fourniture B2B internationale.
Integrated company scope
Xingxu Kangda brings several connected capabilities together around retractable safety syringe development and manufacturing.
Product structures are developed around controlled manual needle retraction and single-use disablement.
Mold development supports the geometry and repeatability required by syringe components.
Assembly equipment and process design connect product development with scalable manufacturing.
Product information, videos and available documents support distributor and institutional evaluation.
Working principles
The company profile is strengthened by showing how technical and commercial discussions are approached.
Product conversations begin with structure, capacity, needle specification and intended market.
Available product videos, certificates and patent documents are presented for direct review.
Buyers can reach the product team through the inquiry form, email or WhatsApp.
Public records in China
The following milestones link to Chinese corporate, media and regulatory records. Planned capacity and project figures are presented as reported at the time, not as current supply commitments.
Public corporate information records Shaanxi Xingxukangda Medical Technology Co., Ltd. as established in Xi'an on 3 April 2023.
Corporate registration recordA Lintong media report stated that phase one of the Xingxu medical-engineering project entered production with two safety-syringe lines.
View public source ↗2024.1003Shaanxi Daily reported a RMB 113 million cooperation project covering hot-runner molds and automated retractable self-disable syringe lines.
View public source ↗2026.0104Shaanxi Medical Products Administration listed a Class II registration for a single-use human venous blood specimen collection container under the company name.
View public source ↗Certification qualité et brevets internationaux
Consultez le certificat ISO 13485 et une sélection de documents de brevets internationaux fournis par Xingxu Kangda.

Certificat 05135233 0001 Rev. 00 couvrant la conception, le développement, la production et la distribution de seringues stériles rétractables autobloquantes.
Voir le PDF original →
Document de brevet de seringue sûre ; titulaire indiqué : LU, WEN-CHIN.
Voir le PDF original →
Brevet IDP000069186 - SAFE SYRINGE ; titulaire indiqué : LU, WEN-CHIN.
Voir le PDF original →
Document de procédure européenne relatif à la technologie de seringue sûre.
Voir le PDF original →
Brevet d'Invention No. 18823 - Safe syringe ; titulaire indiqué : LU, WEN-CHIN.
Voir le PDF original →